Myriad Genetics Inc (MYGN)
32.15
+0.67 +2.13%
NASDAQ
Feb 20, 12:28
Delayed 2m
USD
View All Key Stats
MYGN Key Stats
Income Statement | |
Revenue (TTM) | 807.50M |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 0.26 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 19.80M |
Profitability | |
Gross Profit Margin (Quarterly) | 75.97% |
Profit Margin (Quarterly) | 1.20% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield (TTM) | Upgrade |
Price and Valuation | |
Market Cap | 2.356B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio (TTM) | 2.934 |
PE Ratio (TTM) | 123.65 |
Price to Book Value | 2.214 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio (Quarterly) | Upgrade |
Free Cash Flow (Quarterly) | 35.00M |
Return on Equity (TTM) | Upgrade |
View All MYGN News
MYGN News
-
WireHeadlineTime (ET)
-
Globe Newswire02/15 07:05
-
Globe Newswire02/13 16:05
-
Globe Newswire02/12 07:30
-
Globe Newswire02/11 07:05
-
Yahoo02/11 07:05
-
Yahoo02/08 10:55
-
Yahoo02/08 08:06
-
SA Breaking News02/08 08:00
-
Globe Newswire02/08 07:05
-
SA Breaking News02/06 13:39
View All Events
MYGN Events
Date | Type | Description |
---|---|---|
05/08/2019 07:30 EDT | Misc | Myriad Genetics Inc Third Quarter Earnings Conference Call in 2019 |
05/08/2019 | Earnings | Myriad Genetics Inc Third Quarter Earnings in 2019 Release |
02/05/2019 16:30 EST | Misc | Myriad Genetics Inc Second Quarter Earnings Conference Call in 2019 |
02/05/2019 | Earnings | Myriad Genetics Inc Second Quarter Earnings in 2019 Release |
11/29/2018 08:00 MST | Misc | Myriad Genetics Inc Annual General Meeting in 2018 |
11/06/2018 16:30 EST | Misc | Myriad Genetics Inc First Quarter Earnings Conference Call in 2019 |
11/06/2018 | Earnings | Myriad Genetics Inc First Quarter Earnings in 2019 Release |
08/24/2018 | Misc | Myriad Genetics Inc Annual Report in 2018 |
08/14/2018 16:30 EDT | Misc | Myriad Genetics Inc Fourth Quarter Earnings Conference Call in 2018 |
08/14/2018 | Earnings | Myriad Genetics Inc Fourth Quarter Earnings Results in 2018 |
MYGN Fundamentals
Income Statement View Statement
MYGN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MYGN One Page Reports
- One Page Report Download
MYGN Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 32.15 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.myriad.com
- Investor Relations URL: https://myriad.com/news-center/investor-information/
- HQ State/Province: Utah
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Growth
- Next Earnings Release: May. 08, 2019
- Last Earnings Release: Feb. 05, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.
MYGN Excel Add-In Codes
- Name: =YCI("MYGN","name")
- Description: =YCI("MYGN","description")
- Sector: =YCI("MYGN","sector")
- Industry: =YCI("MYGN","industry")
- Est. Current Fiscal Year End: =YCI("MYGN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MYGN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MYGN Tweets Stocktwits
Advertisement